Arcus Biosciences (RCUS) Stock Highlights

14.62 | +0.76%

2024-11-21 03:14:11

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB680, and Zimberelimab. Arcus conducts clinical trials for different types of cancers such as Prostate, Lung, Colorectal, Pancreatic, and others. The company operates through the single segment being the business of developing and commercializing immunotherapies.

Statistics

Range Today

14.26 15.01

Volume Today 597.9K

Range 1 Year

13.49 20.31

Volume 1 Year 185.52M

Range 3 Year

12.95 49.1

Volume 3 Year 656.84M

Range 10 Year

6.3 49.1

Volume 10 Year 1.01B

Highlights

Market Capitalization 1.63B (small)

Floating Shares 51.44M

Current Price 14.62

Price To Earnings -4.76

Price To Revenue 2.37

Price To Book 2.89

Earnings Per Share -3.46

Payout Ratio 0%

Performance

Latest +0.76%

1 Month -18.55%

3 Months -14.9%

6 Months -13.64%

1 Year +0.07%

3 Years -67.89%

5 Years +94.41%

10 Years -26.9%

Benchmarks

Market Capitalization

88 / 368

Gross Profits

260 / 278

Total Revenue

84 / 300

Total Rank

154 / 368

Free Cashflow

317 / 352

Performance 5 years

75 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.